These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16307183)

  • 1. Osteoblast lineage properties in giant cell tumors of bone.
    Murata A; Fujita T; Kawahara N; Tsuchiya H; Tomita K
    J Orthop Sci; 2005 Nov; 10(6):581-8. PubMed ID: 16307183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis.
    Robinson D; Segal M; Nevo Z
    Pathobiology; 2002-2003; 70(6):333-42. PubMed ID: 12865629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
    Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
    Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.
    Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PF; Holloway AJ; Thomas DM
    Am J Pathol; 2005 Jul; 167(1):117-28. PubMed ID: 15972958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of the stromal cell in giant cell tumor of bone.
    Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
    Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.
    Atkins GJ; Kostakis P; Vincent C; Farrugia AN; Houchins JP; Findlay DM; Evdokiou A; Zannettino AC
    J Bone Miner Res; 2006 Sep; 21(9):1339-49. PubMed ID: 16939392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells.
    Fujita H; Kurokawa K; Ogino T; Ono M; Yamamoto M; Oka T; Nakanishi T; Kobayashi N; Tanaka N; Ogawa T; Suzaki E; Utsumi K; Sasaki J
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):78-84. PubMed ID: 21332944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
    Cowan RW; Singh G; Ghert M
    J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14(+) cells of giant cell tumor of bone.
    Avnet S; Salerno M; Zini N; Alberghini M; Gibellini D; Baldini N
    Am J Pathol; 2013 Apr; 182(4):1357-66. PubMed ID: 23395086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold preferences of mesenchymal stromal cells and adipose-derived stem cells from green fluorescent protein transgenic mice influence the tissue engineering of bone.
    Wittenburg G; Flade V; Garbe AI; Lauer G; Labudde D
    Br J Oral Maxillofac Surg; 2014 May; 52(5):409-14. PubMed ID: 24685477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone.
    Roux S; Amazit L; Meduri G; Guiochon-Mantel A; Milgrom E; Mariette X
    Am J Clin Pathol; 2002 Feb; 117(2):210-6. PubMed ID: 11863217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact.
    Nishimura M; Yuasa K; Mori K; Miyamoto N; Ito M; Tsurudome M; Nishio M; Kawano M; Komada H; Uchida A; Ito Y
    J Orthop Res; 2005 Sep; 23(5):979-87. PubMed ID: 16024207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.
    Steensma MR; Tyler WK; Shaber AG; Goldring SR; Ross FP; Williams BO; Healey JH; Purdue PE
    PLoS One; 2013; 8(7):e69101. PubMed ID: 23922683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL expression is related to the differentiation state of human osteoblasts.
    Atkins GJ; Kostakis P; Pan B; Farrugia A; Gronthos S; Evdokiou A; Harrison K; Findlay DM; Zannettino AC
    J Bone Miner Res; 2003 Jun; 18(6):1088-98. PubMed ID: 12817763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.